Boston Scientific CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
10-K: Boston Scientific Reports Strong 2024 Results Driven by Electrophysiology and Strategic Acquisitions
Boston Scientific's 2024 annual report reveals a significant increase in net sales and adjusted net income, fueled by strong commercial execution and strategic acquisitions.
NYSE
Boston Scientific Corporation filed an amendment to its annual report to include the conformed electronic signature of its independent auditor, Ernst & Young LLP.
NYSE
Boston Scientific's 2023 annual report highlights a year of significant growth, strategic acquisitions, and continued global expansion across its MedSurg and Cardiovascular segments.